Talphera Inc (TLPH) FinancialsTLPHFinancialTalphera Inc

Talphera Inc (TLPH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is DSUVIA, accounting for 88.9% of total sales, equivalent to $224.00K. Another important revenue stream is DZUVEO. Understanding this composition is critical for investors evaluating how TLPH navigates market cycles within the Pharmaceuticals industry.

In the context of the broader market, TLPH competes directly with industry leaders such as EDSA and XLO. With a market capitalization of $63.84M, it holds a leading position in the sector. When comparing efficiency, TLPH's gross margin of N/A stands against EDSA's N/A and XLO's N/A. Such benchmarking helps identify whether Talphera Inc is trading at a premium or discount relative to its financial performance.

Talphera has shown a significant increase in its stock price over the past year, with a 122.22% increase, although it currently reports negative earnings and revenue figures.